Indaptus Therapeutics, Inc.
INDP· Nasdaq
Released May 14, 2025, before the open
10-Q filed May 14, 2025, 44 days after period end · 0001641172-25-010099
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$4.53M | -$3.81M | -$4.25M | -$3.37M |
| EPS Diluted | -$9.11 | -$0.45 | -$0.51 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Indaptus Therapeutics, Inc. · CIK 1857044 · Engraved from SEC EDGAR